Opus Genetics Announces Presence at Eyecelerator@AAO 2021
November 08, 2021 08:30 ET
|
Opus Genetics
RALEIGH, N.C., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, today announced that Ben Yerxa,...
Opus Genetics Announces Two Key Leadership Appointments
October 20, 2021 07:30 ET
|
Opus Genetics
Dr. Ash Jayagopal named Chief Scientific OfficerMr. Joe Schachle appointed Chief Operating Officer RALEIGH, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-focused gene therapy...
RD Fund Launches Opus Genetics with $19M Seed Funding to Advance Gene Therapy Treatments for Blinding Conditions
September 22, 2021 07:30 ET
|
Opus Genetics
Initial programs will focus on treatments for rare pediatric blinding conditions Company formed to advance the work of scientific cofounders Dr. Jean Bennett, Junwei Sun and Dr. Eric Pierce ...